Differential role of long terminal repeat control elements for the regulation of basal and Tat-mediated transcription of the human immunodeficiency virus in stimulated and unstimulated primary human macrophages. NLM AIDSLINE Important note: Information in this article was accurate in 1994. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Differential role of long terminal repeat control elements for the regulation of basal and Tat-mediated transcription of the human immunodeficiency virus in stimulated and unstimulated primary human macrophages.

J Virol. 1994 Jan;68(1):298-307. Unique Identifier : AIDSLINE MED/94076420
Moses AV; Ibanez C; Gaynor R; Ghazal P; Nelson JA; Department of Microbiology and Immunology, Oregon Health Sciences; University, Portland 97201.


Abstract: Primary human macrophages induced to differentiate through contact with autologous activated nonadherent cells were used to investigate the transcriptional mechanisms involved in reactivation of human immunodeficiency virus (HIV) replication. Through transient transfection experiments with an HIV long terminal repeat (LTR)-chloramphenicol acetyltransferase reporter construct, we show that macrophage differentiation results in a 20-fold upregulation of basal LTR activity. To identify sequence elements responsive to the differentiation process, point mutations introduced into the LTR were tested in differentiated and undifferentiated macrophages. Several elements were identified as positive regulators of basal transcription. TATA, Sp1, and NF-kappa B binding sites were the most influential. The low-affinity site for LBP-1 (UBP-1) functioned as a negative regulator of LTR activity in undifferentiated macrophages, but this influence was lost upon differentiation. When tat was cotransfected into the expression system, the requirement for LTR elements identified as important for positive regulation of basal transcription remained in undifferentiated macrophages. Interestingly, however, the mutations in positive control elements which debilitated activity in undifferentiated macrophages had no effect on LTR activity in differentiated macrophages. Thus, it appears that while HIV-LTR activity is highly dependent on cellular transcription factors in undifferentiated cells, in differentiated macrophages the viral protein Tat confers pliability on the LTR and facilitates autonomy from absolute cellular control mechanisms. In vivo, release from either positive or negative regulation via cellular proteins may facilitate reactivation of HIV in macrophages.
Keywords: Adult Base Sequence Cell Differentiation DNA Mutational Analysis Enhancer Elements (Genetics)/GENETICS Gene Products, tat/*GENETICS Human HIV/GROWTH & DEVELOPMENT/*GENETICS HIV Long Terminal Repeat/*GENETICS Macrophages/CYTOLOGY/*MICROBIOLOGY Molecular Sequence Data Promoter Regions (Genetics)/GENETICS Regulatory Sequences, Nucleic Acid/*GENETICS Support, Non-U.S. Gov't Support, U.S. Gov't, P.H.S. Transcription Factors/METABOLISM *Transcription, Genetic Virus Latency/GENETICS Virus Replication JOURNAL ARTICLEKWDadultbasesequencecelldifferentiationdnamutationalanalysisenhancerelements(genetics)/geneticsgeneproducts,tat/KWDgeneticshumanhiv/growth&development/KWDgeneticshivlongterminalrepeat/KWDgeneticsmacrophages/cytology/KWDmicrobiologymolecularsequencedatapromoterregions(genetics)/geneticsregulatorysequences,nucleicacid/KWDgeneticssupport,non-uKWDsKWDgov'tsupport,uKWDsKWDgov't,pKWDhKWDsKWDtranscriptionfactors/metabolismKWDtranscription,geneticviruslatency/geneticsvirusreplicationjournalarticle
940330
M9430611

Copyright © 1994 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1994. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1994. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .